Pressure BioSciences given grant for pathogen detection technology

Pressure BioSciences, based in South Easton, Massachusetts, recently announced that it was the recipient of a $649,000 grant from the U.S. Department of Defense for the development of pathogen detection technology.

The grant, which is to be paid over a two year period, will be used to develop the company’s automated pressure cycling technology that aids in the detection of dangerous bioagents, according to

Pressure BioSciences also announced that the grant would cover a substantial portion of the remaining costs of developing its PCT platform, which allows for the safe, rapid and reproducible extraction of DNA, RNA and proteins from differing kinds of cells and tissues.

"The detection of dangerous pathogens in the field is essential to protect soldiers, emergency responders, and others against possible exposure to biological threat agents,” the company said in a statement, reports. "Such detection requires the safe and rapid inactivation of infectious samples and the simultaneous extraction of biomolecules from the pathogen, including highly dangerous bacteria such as anthrax."

During the term of the grant, Pressure BioSciences intends to team up with scientists from the U.S. Army Medical Research Institute of Infectious Diseases and the University of Texas Medical Branch. It also plans to adapt the new PCT system for both research and clinical diagnostics laboratory use.

Organizations in this Story

U.S. Department of Defense

Want to get notified whenever we write about U.S. Department of Defense ?
Next time we write about U.S. Department of Defense, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.